Globe Life (GL) Expected to Release Quarterly Earnings on Wednesday

Globe Life (NYSE:GL) will likely be releasing its Q2 2026 results after the market closes on Wednesday, July 22nd. Analysts expect the company to announce earnings of $3.67 per share and revenue of $1.5904 billion for the quarter. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Interested persons can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, July 23, 2026 at 11:00 AM ET.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm earned $3.07 EPS. The firm’s revenue was up 5.3% on a year-over-year basis. On average, analysts expect Globe Life to post $16 EPS for the current fiscal year and $17 EPS for the next fiscal year.

Globe Life Trading Up 0.3%

Shares of GL stock opened at $179.16 on Wednesday. Globe Life has a 1 year low of $117.74 and a 1 year high of $182.32. The stock has a fifty day moving average of $164.69 and a two-hundred day moving average of $150.74. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a market capitalization of $13.91 billion, a PE ratio of 12.39 and a beta of 0.47.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is currently 9.13%.

Insider Activity at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 7,936 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the completion of the sale, the chief financial officer directly owned 50,496 shares of the company’s stock, valued at approximately $7,907,168.64. This represents a 13.58% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael Clay Majors sold 34,000 shares of the firm’s stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at $8,231,603.58. The trade was a 38.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 124,187 shares of company stock worth $19,529,414. Insiders own 2.11% of the company’s stock.

Hedge Funds Weigh In On Globe Life

A number of large investors have recently made changes to their positions in the business. Invesco Ltd. grew its position in Globe Life by 2.7% during the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after purchasing an additional 102,445 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Globe Life by 2.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock valued at $298,732,000 after acquiring an additional 59,629 shares in the last quarter. Morgan Stanley grew its holdings in shares of Globe Life by 7.2% during the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after acquiring an additional 125,567 shares in the last quarter. AQR Capital Management LLC increased its stake in shares of Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the last quarter. Finally, Nuveen LLC raised its holdings in shares of Globe Life by 20.4% during the fourth quarter. Nuveen LLC now owns 1,374,302 shares of the company’s stock worth $192,210,000 after acquiring an additional 233,145 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Truist Financial upped their price objective on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Wells Fargo & Company lifted their target price on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Morgan Stanley lifted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Finally, Piper Sandler boosted their target price on shares of Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and an average price target of $182.10.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.